Exosome-cargoed microRNAs: Potential therapeutic molecules for diabetic wound healing

Ruohan Lou1, Jiali Chen1, Fei Zhou1

  • 1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao 999078, China.

Drug Discovery Today
|July 22, 2022
PubMed

Insights

Exosomal microRNAs show promise for treating diabetic foot ulcers by improving blood vessel formation. These novel therapeutics offer a compatible option for accelerating diabetic wound healing.

Area of Science:

  • Biomedical Science
  • Regenerative Medicine
  • Molecular Biology

Background:

  • Diabetic foot ulcers are a major complication of diabetes, often leading to amputation.
  • Current treatments are limited, necessitating exploration of novel therapeutic approaches.
  • Impaired angiogenesis, due to factors like endothelial dysfunction and stenosis, hinders diabetic wound healing.

Purpose of the Study:

  • To review current knowledge on exosomal microRNAs in regulating angiogenesis.
  • To explore the role of exosomal microRNAs in accelerating diabetic wound healing.
  • To identify targets and mechanisms of exosomal microRNAs in diabetic wound repair.

Main Methods:

  • Literature review of exosomal microRNAs and angiogenesis.
  • Analysis of microRNA targets and regulatory pathways.
  • Evaluation of exosomal microRNAs as potential therapeutics for diabetic wounds.

Main Results:

  • Exosomal microRNAs are key regulators of angiogenesis during wound healing.
  • These microRNAs influence endothelial cell function and vascularization.
  • Specific microRNAs have been identified as crucial for promoting wound closure.

Conclusions:

  • Exosomal microRNAs represent a promising therapeutic strategy for diabetic foot ulcers.
  • Their ability to modulate angiogenesis offers a novel approach to accelerate healing.
  • Exosomal microRNAs demonstrate good biocompatibility and minimal rejection, suitable for therapeutic applications.

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K